Home   中文简体 中文繁體 
Company News Products R&D Investor relationship Human Resource Contact Us
 
 
 
News
 
The Company determined the issue price range of the Issue of A Shares   2020-06-05
       After the completion of the preliminary price consultation with the price consultation participants on 3 June 2020 and excluding the highest quoted portion of the total volume of proposed subscriptions, the Company and the joint lead underwriters determined the offer price range to be from RMB8.65 per share to RMB8.95 per share through negotiation, taking into account of the Company’s fundamentals, industry conditions and the price earning ratios of comparable companies. The difference between the upper and lower limits of the offer price range does not exceed 20% of the lower limit of the offer price range. The Company will determine the offer price of the Issue of A Shares by cumulative tender price consultation with the price consultation participants that provide a valid price quote within the offer price range on 8 June 2020.
Links  |  SiteMap  |  Privacy Copyright© Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 2007
(沪)-非经营性-2019-0143    沪ICP备10027510号-1